| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Alcoholism 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] DRD2 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 2 | Calcium signaling pathway 8 genes, 1 drug (DrugBank), 1 disease shown |
[8] CHRM1, CHRM2, CHRM3, CHRM5, HRH1, HTR2A, HTR2B, HTR2C |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 3 | cAMP signaling pathway 3 genes, 1 drug (DrugBank), 1 disease shown |
[3] CHRM1, CHRM2, DRD2 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 4 | cGMP-PKG signaling pathway 3 genes, 1 drug (DrugBank), 1 disease shown |
[3] ADRA2A, ADRA2B, ADRA2C |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 5 | Cholinergic synapse 5 genes, 1 drug (DrugBank), 1 disease shown |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 6 | Cocaine addiction 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] DRD2 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 7 | Dopaminergic synapse 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] DRD2 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 8 | Ferroptosis 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] HMOX1 |
D05922 |
Stannsoporfin |
[1] 254 |
| 9 | Fluid shear stress and atherosclerosis 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] HMOX1 |
D05922 |
Stannsoporfin |
[1] 254 |
| 10 | Gap junction 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] DRD2, HTR2A, HTR2B, HTR2C |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 11 | Gastric acid secretion 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CHRM3 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 12 | Glycine, serine and threonine metabolism 2 genes, 1 drug (DrugBank), 1 disease shown |
[2] ALAS1, ALAS2 |
D10003 |
Hemin |
[1] 254 |
| 13 | Hepatocellular carcinoma 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] HMOX1 |
D05922 |
Stannsoporfin |
[1] 254 |
| 14 | HIF-1 signaling pathway 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] HMOX1 |
D05922 |
Stannsoporfin |
[1] 254 |
| 15 | Inflammatory mediator regulation of TRP channels 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] HRH1, HTR2A, HTR2B, HTR2C |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 16 | Insulin secretion 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CHRM3 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 17 | Metabolic pathways 4 genes, 2 drugs (DrugBank), 1 disease shown |
[2] ALAS1, ALAS2 |
D10003 |
Hemin |
[1] 254 |
| [2] HMOX1, HMOX2 |
D05922 |
Stannsoporfin |
[1] 254 |
| 18 | MicroRNAs in cancer 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] HMOX1 |
D05922 |
Stannsoporfin |
[1] 254 |
| 19 | Mineral absorption 2 genes, 1 drug (DrugBank), 1 disease shown |
[2] HMOX1, HMOX2 |
D05922 |
Stannsoporfin |
[1] 254 |
| 20 | Neuroactive ligand-receptor interaction 13 genes, 1 drug (DrugBank), 1 disease shown |
[13] ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 21 | Pancreatic secretion 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CHRM3 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 22 | Parkinson disease 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] DRD2 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 23 | Pathways in cancer 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] HMOX1 |
D05922 |
Stannsoporfin |
[1] 254 |
| 24 | PI3K-Akt signaling pathway 2 genes, 1 drug (DrugBank), 1 disease shown |
[2] CHRM1, CHRM2 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 25 | Porphyrin and chlorophyll metabolism 4 genes, 2 drugs (DrugBank), 1 disease shown |
[2] ALAS1, ALAS2 |
D10003 |
Hemin |
[1] 254 |
| [2] HMOX1, HMOX2 |
D05922 |
Stannsoporfin |
[1] 254 |
| 26 | Rap1 signaling pathway 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] DRD2 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 27 | Regulation of actin cytoskeleton 5 genes, 1 drug (DrugBank), 1 disease shown |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 28 | Salivary secretion 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CHRM3 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 29 | Serotonergic synapse 3 genes, 1 drug (DrugBank), 1 disease shown |
[3] HTR2A, HTR2B, HTR2C |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |
| 30 | Taste transduction 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CHRM3 |
D00270 |
Chlorpromazine |
[1] 254 |
| D00789 |
| D03274 |
| D04034 |